Dose-Response Relationship, Drug
"Dose-Response Relationship, Drug" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The relationship between the dose of an administered drug and the response of the organism to the drug.
| Descriptor ID |
D004305
|
| MeSH Number(s) |
G07.690.773.875 G07.690.936.500
|
| Concept/Terms |
Dose-Response Relationship, Drug- Dose-Response Relationship, Drug
- Dose-Response Relationships, Drug
- Drug Dose-Response Relationship
- Drug Dose-Response Relationships
- Relationship, Drug Dose-Response
- Relationships, Drug Dose-Response
- Dose Response Relationship, Drug
|
Below are MeSH descriptors whose meaning is more general than "Dose-Response Relationship, Drug".
Below are MeSH descriptors whose meaning is more specific than "Dose-Response Relationship, Drug".
This graph shows the total number of publications written about "Dose-Response Relationship, Drug" by people in this website by year, and whether "Dose-Response Relationship, Drug" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 61 | 61 |
| 1995 | 1 | 49 | 50 |
| 1996 | 0 | 45 | 45 |
| 1997 | 0 | 55 | 55 |
| 1998 | 0 | 66 | 66 |
| 1999 | 0 | 90 | 90 |
| 2000 | 0 | 102 | 102 |
| 2001 | 0 | 96 | 96 |
| 2002 | 0 | 128 | 128 |
| 2003 | 0 | 160 | 160 |
| 2004 | 0 | 153 | 153 |
| 2005 | 1 | 155 | 156 |
| 2006 | 1 | 121 | 122 |
| 2007 | 3 | 138 | 141 |
| 2008 | 0 | 137 | 137 |
| 2009 | 1 | 128 | 129 |
| 2010 | 2 | 121 | 123 |
| 2011 | 2 | 111 | 113 |
| 2012 | 0 | 94 | 94 |
| 2013 | 3 | 101 | 104 |
| 2014 | 1 | 122 | 123 |
| 2015 | 3 | 103 | 106 |
| 2016 | 0 | 81 | 81 |
| 2017 | 0 | 93 | 93 |
| 2018 | 3 | 84 | 87 |
| 2019 | 1 | 69 | 70 |
| 2020 | 1 | 59 | 60 |
| 2021 | 2 | 59 | 61 |
| 2022 | 0 | 8 | 8 |
| 2023 | 0 | 6 | 6 |
| 2024 | 3 | 19 | 22 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dose-Response Relationship, Drug" by people in Profiles.
-
ROMI: a randomized two-stage basket trial design to optimize doses for multiple indications. Biometrics. 2024 Oct 03; 80(4).
-
Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues. Eur J Med Chem. 2024 Dec 05; 279:116904.
-
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease. N Engl J Med. 2024 Sep 19; 391(11):1002-1014.
-
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors. J Clin Oncol. 2024 Oct 10; 42(29):3443-3452.
-
Adverse effects associated with antipsychotic use in older adults. Expert Opin Drug Saf. 2024 Sep; 23(9):1157-1171.
-
Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline. Support Care Cancer. 2024 Jul 24; 32(8):542.
-
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA). Gastroenterology. 2024 Oct; 167(5):1008-1018.e5.
-
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial. JAMA Cardiol. 2024 Jul 01; 9(7):620-630.
-
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia. N Engl J Med. 2024 Sep 12; 391(10):913-925.
-
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia. N Engl J Med. 2024 Sep 12; 391(10):899-912.